Loading candles…
Sai Life Sciences Ltd was incorporated in 1999 and operates in the pharmaceutical and biotechnology industries. The company provides contract research, development, and manufacturing services, focusing on supporting drug discovery, development, and commercial manufacturing for New Chemical Entities. Sai Life Sciences conducts its operations through innovative research laboratories located in global hubs and cost-efficient, large-scale manufacturing facilities in India. It maintains relationships with 18 of the top 25 global pharmaceutical companies and serves over 300 active customers worldwide, including markets in the US, UK, Europe, Japan, and India. The company's business segments include contract research, development, and manufacturing services for its clients in the pharma and biotech sectors.
This page is a live market overview for SAI LIFE SCIENCES LIMITED (SAILIFE) on the NSE. As a listed security, SAI LIFE SCIENCES LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SAILIFE before placing trades on tick2trade.
As of the latest feed, SAILIFE last traded at ₹1,365.2 on NSE, down ₹48.3 (3.42%) from the previous close of ₹1,413.5. Today's session range is ₹1,319.5 – ₹1,398.3, against a 52-week band of ₹778.5 – ₹1,398.3. Traded volume today stands at 9.31L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SAILIFE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SAILIFE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SAI LIFE SCIENCES LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SAILIFE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SAILIFE option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Audited Results - FY26 | To consider and approve the Un Audited financial results for the period ended Jun 30, 2026 | 6 Aug 2026 |
| Audited Results - Q4 & FY26 | To consider and approve the Audited Financial Results (Standalone & Consolidated) for the fourth quarter and year ended March 31, 2026 | 14 May 2026 |
| Unaudited Results - Q3-FY25 | To consider and approve the Un-audited Financial Results for the third quarter and nine months ended December 31, 2025. | 5 Feb 2026 |
| Unaudited Results - FY25 | To consider and approve the Un-audited financial results (Standalone and Consolidated) for the period ended September 30, 2025 | 6 Nov 2025 |
| Unaudited Results - Q1-FY25 | To consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended Jun 30, 2025 | 7 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and other business matters | 13 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.